Cannabis News

Missouri Bill To Restrict Hemp THC Products Stalls Amid Senate Filibuster

Published

2 months ago

February 14, 2026

admin

“We have to make sure we don’t have unintended consequences, and destroy things that don’t need to be destroyed.”

By Rebecca Rivas, Missouri Independent

A push for Missouri’s immediate approval of planned federal limits on intoxicating hemp products emerged Wednesday in the state Senate, with critics urging any changes to wait until national regulations take effect in November.

Democratic state Sen. Karla May of St. Louis led the two-hour filibuster invoice that would immediately ban hemp-derived THC beverages and edibles as soon as the legislation is passed and becomes law.

May argued in a Senate debate on Wednesday that the federal limits will be changed before they are implemented later this year. Congress passed a provision to ban these products as part of the federal spending package last year.

offered one correction which would align the Senate bill with a the proposal Sponsored by Republican state Rep. Dave Hinman of O’Fallon, Missouri would be allowed to sell the products nationwide if Congress allows it.

Hinman’s bill has cleared a House committee and is ready for debate by the full chamber.

“When Congress voted on this whole thing, this was literally reopening the government,” May said. “I mean, this wasn’t even a thoughtful conversation.”

The bill debated Wednesday afternoon, sponsored by Republican state Sen. David Gregory Chesterfield, would prohibit hemp products from containing more than 0.4 milligrams of THC per container and from having a THC concentration of no more than 0.3 percent by dry weight, delta-9 THC. These reflect federal boundaries.

Intoxicating hemp products containing as much as 1,000 mg of THC are being sold in smoke shops—outside of licensed marijuana dispensaries in Missouri—and are not regulated by any government agency. Missouri lawmakers have not passed legislation regulating these products since 2023.

Gregory has argued that his bill and the federal provision close loopholes left in the 2018 Farm Bill when Congress legalized hemp.

“My bill continues the intent of Congress three months ago, and of course our great people in Missouri,” Gregory said, “which is that if you get drunk from the cannabis plant, it’s marijuana and it should be heavily regulated under these specific rules.”

May has been a consistent critic of attempts to ban intoxicating hemp products outright, arguing that they should be regulated.

May said the amendment she offered to Gregory’s bill Wednesday was a “good compromise” because it would still align state and federal lines if Congress rewrites the federal boundaries.

“It’s not about removing your tongue,” May told Gregory. “And if (Congress) does nothing, your language will be the law of the land of Missouri.”

Gregory said his amendment went “a little too far” for him because Missouri would do “what the feds tell us.” He said these products urgently need to be regulated to protect children.

After more than two hours of debate, the Senate was forced to adjourn when it failed to get enough lawmakers from the chamber to form a quorum.

State officials estimated in 2024 that 40,000 food establishments and smoke shops and 1,800 food manufacturers were selling products that would be banned under the proposed federal regulations. This includes low-THC seltzers such as Mighty Kind and Triple, which have grown in popularity in liquor stores and bars.

May said lawmakers should consider those businesses when making decisions.

“It’s a complicated situation,” May said. “And I think we need to make sure we don’t have unintended consequences, and destroy things that don’t need to be destroyed.”

Hinman told The Independent Thursday that he spent about 20 hours this week working on his bill, so he expected it wouldn’t face the same hurdles Gregory faced during a full-house debate.

“There’s so much involved in this,” Hinman said, “and trying to legalize that is very difficult.”

He said there are three potential scenarios that could play out before November, when the federal limits go into effect.

The feds can continue with the current limits, he said, which “puts all hemp businesses out of business.” Congress could redefine what constitutes hemp and change the limit of 0.4 milligrams of THC per container to allow low-THC drinks and edibles.

“So in that case, we’re looking at what would happen if we changed that piece of the puzzle,” he said.

The third option is if Congress approves a two-year extension, he said, and “go for it.” That would mean Missouri would have to put some sort of regulation in place in the meantime, he said.

“We’re trying to write legislation that would effectively cover those three things,” he said, “So we’re trying to achieve the goal of making these hard negotiations successful for everyone in this market, if federal law is possible.”

This story was first published by the Missouri Independent.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

Nascent medical cannabis industry aims for growth

Published

8 hours ago

April 18, 2026

admin

The medicinal cannabis sector is struggling to take root, and another specialist processing plant is set to close. But with current regulations and a new collective industry in mind, New Zealanders are promising to reduce their reliance on imported medicinals.

There was great excitement when medicinal cannabis was legalized and then regulated in 2020, with the hope of growing the domestic sector and serving patients here and abroad. However, since then, several companies have closed their doors, including Greenfern Industries, Cannasouth and, most recently, Helius Therapeutics.

The latter plans to close the East Tāmaki plant, affecting 65 workers. It is one of the few medicinal cannabis factories in the entire nation that has a specialized processing certificate called “Good Manufacturing Practice” (GMP).

Medical Cannabis Council executive director Sally King said that under current rules, most growers did not have such certification, and could only sell raw ingredients, not processed products such as more profitable cannabis capsules.

Cannabis News

Medical Marijuana Helps People Stop Using Opioids, Sleeping Aids And Other Prescription Drugs, Study Shows

Published

9 hours ago

April 17, 2026

admin

Using medical marijuana appears to help reduce the use of other medications, including opioids, sleep aids and antidepressants, according to a new study of more than 3,500 patients. They experience far fewer negative side effects after switching from prescription drugs to cannabis.

The survey results show that across all medication categories, patients were able to reduce their use of other prescription drugs by an average of 84.5 percent after starting to use medical cannabis.

More than half of the patients (58.9 percent) completely stopped using other prescription drugs.

The study, conducted and published by medical cannabis and telehealth company Bloomwell, conducted an online survey of 3,528 patients in Germany last month.

“Through the use of medical cannabis, patients were able to reduce their use of other prescription medications by an average of 84.5% across all categories.”

93.4 percent of patients taking sleeping pills were able to cut their use in half after starting medical marijuana, and 75.5 percent were able to get off the medication completely.

For methylphenidate, an ADHD drug sold under the name Ritalin, 77.3 percent of medical marijuana patients stopped completely.

61 percent of patients who were previously dependent on opioids were able to stop completely with the help of medical marijuana.

Stopping the use of prescription drugs led to a significant reduction in drug-related side effects, with 60.7 percent reporting no longer experiencing them.

“These patient reports demonstrate that in many cases, in addition to the treatment of the actual symptoms, one of the key reasons for an individual therapeutic trial with medical cannabis is the absence or reduction of medication-related side effects,” the study concluded.

“60.7% of patients reported no longer experiencing medication-related side effects from using medical cannabis.”

There were positive side effects, however, with 67.8 percent saying medical cannabis helped them concentrate better, 61.9 percent said it helped them foster more social relationships, and 53.9 percent experienced fewer sick days from work.

“The primary reason for prescribing medicinal cannabis, in addition to treating symptoms, is to reduce or avoid the side effects of other medications,” Julian Wichmann, Bloomwell’s founder and CEO, said in a press release. “For example, anyone who can completely stop opioids using medical cannabis has a good chance of going about their daily lives and working without side effects.”

“So we shouldn’t demand restrictions on access to medical cannabis, but rather make sure doctors are willing to do an individual therapeutic trial with medical cannabis, or at least recommend it and refer patients to their colleagues,” he said. “At the same time, our survey shows that we should finally discuss the great benefits of medical cannabis more openly, instead of only warning about the empirically unproven risks and discrediting the flower.”

This is not the first study to position medical cannabis as a safer alternative to opioids and other prescription drugs.

About One in three Americans who use CBD say they take it as an alternative or supplement to at least one medication—especially painful ones—according to a federally funded study published in February.

Also, a recent federally funded study, published by the American Medical Association (AMA), added further evidence Marijuana can be an effective substitute for opioids in the treatment of chronic pain.

Other studies published by the AMA have found legalizing marijuana for medical or recreational purposes “Significantly associated with reduced opioid use among patients diagnosed with cancer.”

A separate paper published in October also found that Legalizing medical marijuana “is associated with a significant reduction in opioid prescriptions.”

In August, however, Australian researchers published a study that shows this Marijuana can be an effective substitute for opioids in pain management treatment.

Another study published last year in the journal Drug and Alcohol Review found that daily drug users with chronic pain cannabis use was associated with greater likelihood of opioid cessation-Especially among men.

Other studies also found this legalizing medical cannabis appears to have significantly reduced payments to doctors from opioid manufacturers who specialize in pain, the authors found that “this reduction is a consequence of the availability of medical marijuana as a substitute” for prescription analgesics.

Other recent studies also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That research found a ‘consistent negative relationship’ between legalization and fatal overdoses, effects more pronounced in states that legalized cannabis earlier in the opioid crisis. The authors estimated that legalizing recreational marijuana “is associated with a decrease of 3.5 deaths per 100,000 people.”

“Our findings suggest that expanding access to recreational marijuana could help combat the opioid epidemic,” the report said. “Prior studies overwhelmingly indicate that marijuana (especially for medical use) can reduce opioid prescriptions, and we see it successfully reducing overdose deaths as well.”

Another recently published report on prescription opioid use in Utah follows the state legalizing medical marijuana found that the availability of legal cannabis reduced opioid use among chronic pain patients and helped reduce prescription drug overdose deaths across the state. Overall, the study’s results indicated that “cannabis plays a significant role in pain management and reducing opioid use,” he said.

President Donald Trump said in December that marijuana can “make people feel a lot better.” and serves as a “substitute for addictive and potentially deadly opioid painkillers.” issued an executive order to federally regulate cannabis and promote access to CBD for therapeutic purposes. He clarified, however, that he personally has no interest in using marijuana himself.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

More employees mobilize with UFCW

Published

1 day ago

April 17, 2026

admin

United Food and Commercial Workers (UFCW) Local 360 has announced that more cannabis workers in New Jersey are joining its union family. Workers at Hamilton, New Jersey-based cannabis product manufacturer Sun Extractions chose to unionize with Local 360 for the better wages, benefits and benefits that come with a union contract.

Their decision adds to the growing momentum of UFCW Local 360’s Cannabis Workers Rising campaign, which has helped shape statewide labor standards and increase worker, consumer and community safety in New Jersey’s fledgling legal marijuana industry.

“New Jersey’s cannabis industry is stronger today thanks to this vote by Sun Extractions workers,” said Hugh Giordano, UFCW Local 360 Organizing Director. “Sustainable success for companies, workers and communities starts with fair treatment, strong standards and shared commitments. This is how jobs in the cannabis industry become long-term careers, and the future these workers work for.”

“It’s great that this vote is being announced before 4/20,” Giordano added. “4/20 used to be about the plant, but it has become a holiday that celebrates the entire cannabis community and recognizes the workers who grow, cut, pack, package, advise and distribute our cannabis products. Their hard work is why New Jersey’s medical and adult markets are safe and growing, and why sales are on target to exceed $2 billion this year.”

UFCW Local 360 President Sam Ferraino, Jr. emphasized that the Sun Extractions vote is part of a growing push to improve worker protections and benefits in the legal marijuana industry.

“We have more reasons than ever to celebrate 4/20 this year. We welcome the employees of Sun Extractions to the Local 360 family, seeing the hard work of our members move an entire industry forward, and speaking to other states, looking to New Jersey as a model of how to do it,” said Ferraino. “It’s further proof of what we always say: stronger unions mean stronger industries and communities. And that’s worth celebrating.”

For more than a decade, UFCW Local 360 has been at the forefront of efforts to ensure that New Jersey’s cannabis industry offers fair wages, strong job protections and real advancement opportunities. Thousands of cannabis workers, from cultivation to retail, have joined the union since the Cannabis Workers Rising campaign began.

From seed to sale, UFCW is the national leader in organizing workers in the cannabis industry and is the official cannabis union of the AFL-CIO. In the US, UFCW works with workers and business owners to achieve the shared goal of a regulated cannabis industry that provides family-supporting jobs and promotes social equity.

For more information:
UFCW
www.ufcw.org